Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surgery-Associated Acute Kidney Injury

Ads

You May Also Like

Symphony Health Launches New Long Term Care Channel Offering

CONSHOHOCKEN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Symphony Health, a PRA Health Sciences ...

Biocartis Group NV: Biocartis en AstraZeneca sluiten overeenkomst gericht op snellere biomarker resultaten voor longkanker

PERSBERICHT: 29 november 2018, 07:00 CET                                    Biocartis en AstraZeneca sluiten overeenkomst                               gericht ...